Dr. Justin E. Dominick, MD

Dr. Dominick practices at Sharp Rees-Stealy Medical Group, Inc in San Diego, California.

Dr. Dominick's NPI, 1669497038, was assigned on July 13, 2006. Dr. Dominick graduated from The Warren Alpert Medical School of Brown University in 1999. Dr. Dominick holds California license A75156.

Dr. Dominick's primary practice is Sharp Rees-Stealy Medical Group, Inc, at 5651 Copley Dr, San Diego, CA 92111 in San Diego County. The practice phone is (858) 262-6666.

Dr. Dominick's primary practice is Sharp Rees-Stealy Medical Group, Inc in San Diego, California. Dr. Dominick is also affiliated with Sharp Memorial Hospital. The medical group on file is Scripps Clinic Medical Group. Dmand AI also links Dr. Dominick to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dominick practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Dominick's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Dominick is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Dominick is licensed in California.

Dmand AI lists alzheimer's disease, cerebrovascular disease, epilepsy, essential tremor, fibromyalgia and chronic pain, hereditary polyneuropathy, lower back pain and migraine and chronic headache among the conditions Dr. Dominick treats.

CMS data shows 563 Medicare services from Dr. Dominick across 6 procedure codes in 2024, for 238 Medicare patients. Medicare paid $41,157 for them. Every service was in an office.

CMS counts 238 Medicare patients who saw Dr. Dominick in 2024. The largest group is 75 to 84, with 102 patients. 63% of them have high cholesterol, and 62% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dominick's median patient age at 69, with 61% women.

In 2024, Dr. Dominick wrote 2,697 Medicare Part D claims for 471 patients. 91% of them were for generic drugs. CMS names the drug for 2,502 of them, across 56 drugs with 11 or more claims each, at $581,848 in total drug cost. In 2023, CMS named 2,380 claims across 50 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Dominick for performance year 2024, reported as part of a group. Dr. Dominick accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dominick as offering telehealth.

Dmand AI links 3 papers to Dr. Dominick in 2020. Dr. Dominick's most frequent co-authors are John Jing-Wei Chen, MD, PhD, Ian David Ferguson, MD and Eoin Paul Flanagan, MBCHB.

CMS Open Payments shows 124 general payments to Dr. Dominick from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $314.

Dmand AI lists 2 awards for Dr. Dominick, most recently CMS Stage 1 EHR in 2014.

Dr. Dominick graduated from The Warren Alpert Medical School of Brown University in 1999.

Dr. Dominick is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.